Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott M Matson

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Chest|December 5, 2022
Treatment Outcomes for Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Real-World, Multisite Study of the Impact of Immunosuppression on Pulmonary Function TrajectoryScott M Matson, Misbah Baqir, Teng Moua, et al.
Arthritis Care & Research|December 15, 2025
Combining Three Peripheral Blood Biomarkers to Stratify Rheumatoid Arthritis-Associated Interstitial Lung Disease RiskKelsey Coziahr, Austin M Wheeler, Brent A Luedders, et al.
Medrxiv : the Preprint Server for Health Sciences|June 10, 2024
Proteomic profiling of bronchoalveolar lavage fluid uncovers protein clusters linked to survival in idiopathic forms of interstitial lung diseaseLinh T Ngo, Michaella J Rekowski, Devin C Koestler, et al.
ERJ Open Research|December 17, 2024
Proteomic profiling of bronchoalveolar lavage fluid uncovers protein clusters linked to survival in idiopathic forms of interstitial lung diseaseLinh T Ngo, Michaella J Rekowski, Devin C Koestler, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 20, 2024
Antibodies to Malondialdehyde-Acetaldehyde Adduct Are Associated With Prevalent and Incident Rheumatoid Arthritis-Associated Interstitial Lung Disease in US VeteransNozima Aripova, Geoffrey M Thiele, Michael J Duryee, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 16, 2025
Performance of an Idiopathic Pulmonary Fibrosis-Derived Multibiomarker Panel for Rheumatoid Arthritis-Associated Interstitial Lung DiseaseBrent A Luedders, Daniel Kass, Joshua F Baker, et al.
The Lancet. Respiratory Medicine|June 5, 2026
Rheumatoid arthritis-associated interstitial lung disease: screening, diagnosis, and treatment-an expert group consensus statementJoshua J Solomon, Philippe Dieudé, Scott M Matson, et al.
Critical Care Medicine|October 27, 2022
Wellness and Coping of Physicians Who Worked in ICUs During the Pandemic: A Multicenter Cross-Sectional North American SurveyKaren E A Burns, Marc Moss, Edmund Lorens, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Chest|December 5, 2022
Treatment Outcomes for Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Real-World, Multisite Study of the Impact of Immunosuppression on Pulmonary Function TrajectoryScott M Matson, Misbah Baqir, Teng Moua, et al.
Arthritis Care & Research|December 15, 2025
Combining Three Peripheral Blood Biomarkers to Stratify Rheumatoid Arthritis-Associated Interstitial Lung Disease RiskKelsey Coziahr, Austin M Wheeler, Brent A Luedders, et al.
Medrxiv : the Preprint Server for Health Sciences|June 10, 2024
Proteomic profiling of bronchoalveolar lavage fluid uncovers protein clusters linked to survival in idiopathic forms of interstitial lung diseaseLinh T Ngo, Michaella J Rekowski, Devin C Koestler, et al.
ERJ Open Research|December 17, 2024
Proteomic profiling of bronchoalveolar lavage fluid uncovers protein clusters linked to survival in idiopathic forms of interstitial lung diseaseLinh T Ngo, Michaella J Rekowski, Devin C Koestler, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 20, 2024
Antibodies to Malondialdehyde-Acetaldehyde Adduct Are Associated With Prevalent and Incident Rheumatoid Arthritis-Associated Interstitial Lung Disease in US VeteransNozima Aripova, Geoffrey M Thiele, Michael J Duryee, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 16, 2025
Performance of an Idiopathic Pulmonary Fibrosis-Derived Multibiomarker Panel for Rheumatoid Arthritis-Associated Interstitial Lung DiseaseBrent A Luedders, Daniel Kass, Joshua F Baker, et al.
The Lancet. Respiratory Medicine|June 5, 2026
Rheumatoid arthritis-associated interstitial lung disease: screening, diagnosis, and treatment-an expert group consensus statementJoshua J Solomon, Philippe Dieudé, Scott M Matson, et al.
Critical Care Medicine|October 27, 2022
Wellness and Coping of Physicians Who Worked in ICUs During the Pandemic: A Multicenter Cross-Sectional North American SurveyKaren E A Burns, Marc Moss, Edmund Lorens, et al.
Pageof 4